County
Rowan County Emergency Services EMS Division
Rowan County Emergency Services EMS Division (Rowan, NC) carries 48 drugs across 159 dose entries in its current published protocol, effective 2025-09-01.
Drugs and doses48
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 325–1000 mg | PO | not captured | standing | page 168 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 168 |
| Mild to moderate pain | adult | 15 mg/kg (max 1000 mg) | IV | not captured | standing | page 169 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | page 169 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 169 |
| Mild to moderate pain | peds | 15 mg/kg (max 1000 mg) | IV | not captured | standing | page 169 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | page 131 |
| Other | adult | 1 g/kg | PO | not captured | standing | page 131 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 131 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 131 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | page 20 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 20 |
| Wide-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | page 22 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 2.5–5 mg | NEB | not captured | standing | page 45 |
| Respiratory distress | peds | 1.25–2.5 mg | NEB | not captured | standing | page 45 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 20 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 22 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 24 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 26 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 26 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 325 mg | PO | not captured | standing | page 16 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 12 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 12 |
| Nerve agent exposure | adult | 2 mg | IV/IO/IM | not captured | standing | page 133 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | page 131 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | page 131 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 131 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 131 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 49 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 49 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 g | IV/IO | not captured | standing | page 131 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 g | IV/IO | not captured | standing | page 131 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 131 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 131 |
| Hyperkalemia | adult | 2 g | IV/IO | not captured | standing | page 49 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 49 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 141 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 141 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 10 mg | IV/IO/IM | not captured | standing | page 53 |
| Hypotension / shock | peds | 10 mg | IV/IO/IM | not captured | standing | page 53 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 125–250 mL | IV/IO | not captured | standing | page 47 |
| Hypoglycemia | peds | 2 mL/kg | IV/IO | not captured | standing | page 47 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 20 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | PO | not captured | standing | page 45 |
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 45 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | page 45 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 45 |
| Dystonic reaction | adult | 50 mg | IV/IO/IM/PO | not captured | standing | page 182 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 182 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 12 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 45 |
| Anaphylaxis | peds | 0.3–0.5 mg | IM | not captured | standing | page 45 |
| Bradycardia | adult | 1–10 mcg | IV/IO | not captured | standing | page 12 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 12 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 10 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 10 |
| Stridor | adult | 1 mg | NEB | not captured | standing | page 68 |
| Stridor | peds | 1 mg | NEB | not captured | standing | page 68 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 66 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 50–75 mcg | IV/IO | not captured | standing | page 16 |
| CHF / pulmonary edema | adult | 1 mcg/kg | IV/IO | not captured | standing | page 87 |
| CHF / pulmonary edema | peds | 1 mcg/kg | IV/IO | not captured | standing | page 87 |
| Other | adult | 50–75 mcg | IV/IO | not captured | standing | page 34 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 131 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 131 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 131 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 131 |
| Hypoglycemia | adult | 1–2 mg | IM | not captured | standing | page 47 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | page 47 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–10 mg | IM | not captured | standing | page 184 |
| Agitation | adult | 2.5–10 mg | IV | not captured | standing | page 184 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 100 mg | IV/IO/IM | not captured | standing | page 53 |
| Hypotension / shock | peds | 25 mg | IV/IO/IM | not captured | standing | page 53 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 122 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.5 mg | NEB | not captured | standing | page 45 |
| Respiratory distress | peds | 0.5 mg | NEB | not captured | standing | page 45 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | page 185 |
| Hyperactive delirium | peds | 2 mg/kg | IM | not captured | standing | page 185 |
| Mild to moderate pain | adult | 0.2 mg/kg | IV/IO | not captured | standing | page 169 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 66 |
| RSI induction | adult | 4 mg/kg | IM | not captured | standing | page 66 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | page 66 |
| RSI induction | peds | 2 mg/kg | IM | not captured | standing | page 66 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO | not captured | standing | page 54 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 24 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 26 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 26 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 2–4 g | IV/IO | not captured | standing | page 60 |
| Respiratory distress | adult | 2 g | IV/IO | not captured | standing | page 68 |
| Respiratory distress | peds | 40 mg/kg | IV/IO | not captured | standing | page 68 |
| Wide-complex tachycardia | adult | 2 g | IV/IO | not captured | standing | page 24 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 26 |
| VF / pulseless VT | peds | 2 g | IV/IO | not captured | standing | page 26 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO | not captured | standing | page 45 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO | not captured | standing | page 45 |
| Hypotension / shock | adult | 125 mg | IV/IO/IM | not captured | standing | page 53 |
| Hypotension / shock | peds | 125 mg | IV/IO/IM | not captured | standing | page 53 |
| Respiratory distress | adult | 125 mg | IV/IO/IM | not captured | standing | page 68 |
| Respiratory distress | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 68 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV/IO/IN | not captured | standing | page 184 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 184 |
| Agitation | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 184 |
| Agitation | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 184 |
| Bradycardia | adult | 2–2.5 mg | IV/IO/IM/IN | not captured | standing | page 12 |
| Hyperactive delirium | adult | 10 mg | IM | not captured | standing | page 185 |
| Hyperactive delirium | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 185 |
| Other | adult | 2–2.5 mg | IV/IO | not captured | standing | page 34 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 173 |
| Seizure | adult | 2–2.5 mg | IV/IO | not captured | standing | page 173 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 173 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 173 |
| Narrow-complex tachycardia | adult | 2–2.5 mg | IV/IO | not captured | standing | page 20 |
| Wide-complex tachycardia | adult | 2–2.5 mg | IV/IO | not captured | standing | page 22 |
| Wide-complex tachycardia | adult | 2–2.5 mg | IV/IO | not captured | standing | page 24 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–4 mg | IV/IO | not captured | standing | page 16 |
| CHF / pulmonary edema | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 87 |
| CHF / pulmonary edema | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 87 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IM/IN | not captured | standing | page 14 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO/ET | not captured | standing | page 14 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 14 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/ET | not captured | standing | page 14 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 3 doses rapidly | IM | not captured | standing | page 133 |
| Nerve agent exposure | peds | 1-2 doses | IM | not captured | standing | page 133 |
| Organophosphate poisoning | adult | 3 doses rapidly | IM | not captured | standing | page 133 |
| Organophosphate poisoning | peds | 1-2 doses | IM | not captured | standing | page 133 |
Nicardipine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | IV/IO | not captured | standing | page 54 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.3 mg | SL | not captured | standing | page 16 |
| CHF / pulmonary edema | adult | 0.3 mg | SL | not captured | standing | page 18 |
Nitrous Oxide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 70:30 to 50:50 Mix | NEB | not captured | standing | page 169 |
| Mild to moderate pain | peds | 70:30 to 50:50 Mix | NEB | not captured | standing | page 169 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO/ODT | not captured | standing | page 157 |
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO/ODT | not captured | standing | page 157 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | page 157 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | page 157 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 tube or packet | PO | not captured | standing | page 100 |
| Hypoglycemia | peds | 1 tube or packet | PO | not captured | standing | page 100 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 167 |
| Other | peds | 1–2 spray | IN | not captured | standing | page 167 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 56 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IV/IO/IM | not captured | standing | page 133 |
| Nerve agent exposure | peds | 15–25 mg/kg | IV/IO/IM | not captured | standing | page 133 |
| Organophosphate poisoning | adult | 600 mg | IV/IO/IM | not captured | standing | page 133 |
| Organophosphate poisoning | peds | 15–25 mg/kg | IV/IO/IM | not captured | standing | page 133 |
Procainamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 20–50 mg | IV/IO | not captured | standing | page 22 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IV/IO/IM/PO | not captured | standing | page 157 |
| Nausea / vomiting | adult | 12.5 mg | IV/IO/IM/PO | not captured | standing | page 157 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 66 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | page 49 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 49 |
| Tricyclic overdose | adult | 50 mEq | IV/IO | not captured | standing | page 131 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 131 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 66 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 1–2 g | IV/IO | not captured | standing | page 57 |
| Obstetric hemorrhage | peds | 20 mg/kg | IV/IO | not captured | standing | page 57 |
| Trauma / hemorrhage | adult | 1–2 g | IV/IO | not captured | standing | page 53 |
| Trauma / hemorrhage | peds | 20 mg/kg | IV/IO | not captured | standing | page 53 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 40 unit | IV/IO | not captured | standing | page 211 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO | not captured | standing | page 34 |
| Post-intubation sedation | adult | 10 mg | IV/IO | not captured | standing | page 76 |